Voyager Therapeutics, Inc. — Form D

Voyager Therapeutics, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-03. The offering totals $39.0M, of which $39.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Michael W HigginsDirectorCambridge, MA
Todd W CarterExecutive OfficerCambridge, MA
Robert W HessleinExecutive OfficerCambridge, MA
Robin W SwartzExecutive OfficerCambridge, MA
Steven PaulDirectorBoston, MA
Steven PaulExecutive OfficerBoston, MA
MICHAEL HIGGINSDirectorFRAMINGHAM, MA
James A GeraghtyDirectorLexington, MA
Grace A ColonDirectorLexington, MA
Glenn A PierceDirectorLexington, MA
Steven A HymanDirectorLexington, MA
George A ScangosDirectorLexington, MA
Peter PfreundschuhExecutive OfficerLexington, MA
Jacquelyn Fahey SandellExecutive OfficerLexington, MA
Nancy A VitaleDirectorLexington, MA
Alfred SandrockDirectorLexington, MA
Alfred SandrockExecutive OfficerLexington, MA
Robin SwartzExecutive OfficerLexington, MA
Jude A OnyiaDirectorLexington, MA
Catherine A MackeyDirectorLexington, MA
Todd CarterExecutive OfficerLexington, MA
Mark LevinDirectorNew York, NY
James GeraghtyDirectorCambridge, MA
Mitchell S BloomExecutive OfficerNew York, NY

Other filings by this issuer (2)

FiledFormOfferingSold
2024-01-17D$20.0M$20.0M
2015-04-23D$60.0M

More